Literature DB >> 11040242

Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians.

C R Nelson1, D A Knapp.   

Abstract

This study assessed trends from 1980 to 1995 in ambulatory patients' antihypertensive drug therapy by US office-based physicians for visits in which hypertension was the principal diagnosis and compared these trends with the respective guidelines given in 5 Joint National Committee (JNC) Reports on Detection, Evaluation, and Treatment of High Blood Pressure published around the same time period. Data from the National Center for Health Statistics' National Ambulatory Medical Care Surveys for 1980, 1985, 1990, and 1995 were used. From 1980 to 1995, there was no significant trend in the percentage of hypertension visits that did not mention any antihypertensive drug (20% to 27%). Further analyses focused on those hypertension visits in which at least 1 antihypertensive drug was used. Across the years, antihypertensive drug visits mentioning calcium channel blockers or ACE inhibitors significantly increased; those noting diuretics significantly decreased. However, in 1995, antihypertensive drug visits that included a diuretic and/or a beta-adrenergic blocker equalled 53%; these are the antihypertensive drug classes preferred by the JNC V. Physician antihypertensive drug prescribing was generally consistent with the basic antihypertensive drug guidelines of the JNC reports.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040242     DOI: 10.1161/01.hyp.36.4.600

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

Review 1.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

2.  The impact of differences in methodology and population characteristics on the prevalence of hypertension in US adults in 1976-1980 and 1999-2002.

Authors:  Jacqueline D Wright; June Stevens; Charles Poole; Katherine M Flegal; Chirayath Suchindran
Journal:  Am J Hypertens       Date:  2010-03-25       Impact factor: 2.689

3.  Development of explicit criteria to measure adherence to hypertension guidelines.

Authors:  J L Milchak; B L Carter; G Ardery; H R Black; G L Bakris; D W Jones; C D Kreiter
Journal:  J Hum Hypertens       Date:  2006-06       Impact factor: 3.012

4.  Primary care prescribing patterns in Ireland after the publication of large hypertension trials.

Authors:  Zubair Kabir; John Feely; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

5.  Screening, treatment, and control of hypertension in US private physician offices, 2003-2004.

Authors:  Jun Ma; Randall S Stafford
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

6.  Physician and pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; Gail Ardery; Jeffrey D Dawson; Paul A James; George R Bergus; William R Doucette; Elizabeth A Chrischilles; Carrie L Franciscus; Yinghui Xu
Journal:  Arch Intern Med       Date:  2009-11-23

7.  Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients.

Authors:  Macaulay A C Onuigbo; Nnonyelum T C Onuigbo
Journal:  Int Urol Nephrol       Date:  2008-01-15       Impact factor: 2.370

8.  Hypertension guideline adherence among nursing home patients.

Authors:  Paul E Drawz; Cristina Bocirnea; Katarina B Greer; Julian Kim; Florian Rader; Patrick Murray
Journal:  J Gen Intern Med       Date:  2009-02-07       Impact factor: 5.128

9.  Explicit and implicit evaluation of physician adherence to hypertension guidelines.

Authors:  Gail Ardery; Barry L Carter; Jessica L Milchak; George R Bergus; Jeffrey D Dawson; Paul A James; Carrie Franciscus; Yoonsang Kim
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-02       Impact factor: 3.738

10.  A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; George R Bergus; Jeffrey D Dawson; Karen B Farris; William R Doucette; Elizabeth A Chrischilles; Arthur J Hartz
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.